SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

15.13p
   
  • Change Today:
    -1.50p
  • 52 Week High: 26.10
  • 52 Week Low: 13.88
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 2,455,839
  • Market Cap: £39.14m
  • Beta: 0.31

Latest ShareCast News

SkinBioTherapeutics revenue rises fourfold, still misses forecasts

By Josh White

Date: Thursday 14 Aug 2025

(Sharecast News) - SkinBioTherapeutics said in an update on Thursday that revenue for the year ended 30 June were expected to rise almost fourfold to between £4.5m and £4.8m, driven by a full-year contribution from Dermatonics, eight months from Bio-Tech Solutions (BTS), and continued organic growth in AxisBiotix sales.

SkinBioTherapeutics inks Superdrug deal, raises £4.1m

By Josh White

Date: Monday 16 Jun 2025

(Sharecast News) - SkinBioTherapeutics announced on Monday that it has signed an exclusive UK commercial agreement with Superdrug for its 'AxisBiotix' range of food supplements targeting inflammatory skin conditions, while also raising £4.1m through a placing and subscription to support the rollout and related operational needs.

SkinBioTherapeutics shares jump on acquisition of topical cream maker

By Benjamin Chiou

Date: Friday 11 Oct 2024

(Sharecast News) - AIM-listed life sciences company SkinBioTherapeutics has announced the acquisition of Yorkshire-based health, hygiene and personal care products group Bio-Tech Solutions for £1.25m.

SkinBioTherapeutics reports positive results fro... 19-Sep-2024 ShareCast
SkinBioTherapeutics secures £1.56m from new inve... 02-Aug-2024 ShareCast
SkinBioTherapeutics reports better-than-expected... 29-Jul-2024 ShareCast
SkinBioTherapeutics reports positive interim acn... 27-Feb-2024 ShareCast
SkinBioTherapeutics finalises acquisition of Der... 26-Jan-2024 ShareCast
SkinBioTherapeutics launches new consumer study ... 25-Oct-2023 ShareCast
SkinBioTherapeutics gets France approval for pso... 15-Sep-2023 ShareCast
SkinBioTherapeutics selects probiotic blends for... 05-Sep-2023 ShareCast
SkinBioTherapeutics launching psoriasis suppleme... 21-Jun-2023 ShareCast
SkinBioTherapeutics pleased with progress on two... 10-May-2023 ShareCast
SkinBioTherapeutics reports progress with psoria... 17-Feb-2022 ShareCast
SkinBioTherapeutics commercially launches psoria... 29-Oct-2021 ShareCast
SkinBioTherapeutics confirms launch plans for ps... 30-Sep-2021 ShareCast
SkinBioTherapeutics launches research programme ... 08-Apr-2021 ShareCast
SkinBioTherapeutics confident in timelines amid ... 07-Jul-2020 ShareCast
SkinBioTherapeutics to develop psoriasis supplem... 19-Feb-2020 ShareCast
SkinBioTherapeutics strikes deal with chemicals ... 20-Nov-2019 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 15.13p
Change Today -1.50p
% Change -9.02 %
52 Week High 26.10
52 Week Low 13.88
Volume 2,455,839
Shares Issued 258.78m
Market Cap £39.14m
Beta 0.31

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Price Trend
36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Income Not Available
Growth
49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average

SBTX Dividends

No dividends found

Trades for 05-Dec-2025

Time Volume / Share Price
16:16 250,000 @ 15.40p
16:19 12,988 @ 14.91p
16:18 3,381 @ 14.91p
16:17 20,150 @ 14.91p
16:12 20,298 @ 14.80p

SBTX Key Personnel

CEO Stuart Ashman

Top of Page